Ingenus, a generic-drug maker based in Orlando, Florida, used confidential information obtained during a previous research partnership it had with SciDose to develop its own cancer treatment, which doesn’t yet have a name, according to a
The U.S. Food and Drug Administration approved the Ingenus treatment on July 30, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.